Next Article in Journal
Advances in Mesoporous Silica and Hybrid Nanoparticles for Drug Delivery: Synthesis, Functionalization, and Biomedical Applications
Previous Article in Journal
Sulfated Hyaluronan in Dermatology: What’s New? Overview of Evidence in Specific Dermatological Diseases
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Correction

Correction: Sennato et al. Optimization of Lipoplexes Functionalized with a Sialic Acid Mimetic (F9-PEG) to Target the C1858T PTPN22 Variant for Preclinical Assessment of a Novel Immunotherapy in Endocrine Autoimmunity. Pharmaceutics 2025, 17, 710

by
Simona Sennato
1,†,
Giorgia Paldino
2,†,
Cecilia Bombelli
3,
Irene Mezzani
2,
Stefania Petrini
2,
Eugenia Belcastro
2,
Domenico Vittorio Delfino
4,
Francesco Fiorentino
5,
Carlotta Marianecci
5,
Alessia Ciogli
5,
Dante Rotili
6,
Francesca Ceccacci
3,* and
Alessandra Fierabracci
2,*
1
CNR-Institute for Complex Systems (ISC), and Physics Department, Sapienza University of Rome, P. le A. Moro 5, 00185 Rome, Italy
2
Bambino Gesù Children’s Hospital, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), 00146 Rome, Italy
3
CNR-Institute for Biological Systems, Secondary Office of Rome—Sapienza University of Rome, 00185 Rome, Italy
4
Department of Medicine and Surgery, University of Perugia, 06129 Perugia, Italy
5
Department of Drug Chemistry and Technologies, Sapienza University of Rome, 00185 Rome, Italy
6
Department of Science, Roma Tre University, 00146 Rome, Italy
*
Authors to whom correspondence should be addressed.
These authors contributed equally to this work.
Pharmaceutics 2025, 17(12), 1601; https://doi.org/10.3390/pharmaceutics17121601
Submission received: 5 December 2025 / Accepted: 8 December 2025 / Published: 12 December 2025

Addition of an Author

Eugenia Belcastro was not included as an author in the original publication [1]. The corrected authorship and Author Contributions statement appears below. The authors state that the scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original publication has also been updated.
  • Simona Sennato 1,†, Giorgia Paldino 2,†, Cecilia Bombelli 3, Irene Mezzani 2, Stefania Petrini 2, Eugenia Belcastro 2, Domenico Vittorio Delfino 4, Francesco Fiorentino 5, Carlotta Marianecci 5, Alessia Ciogli 5, Dante Rotili 6, Francesca Ceccacci 3,* and Alessandra Fierabracci 2,*
2 
Bambino Gesù Children’s Hospital, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), 00146 Rome, Italy; giorgiapld@gmail.com (G.P.); irene.mezzani@opbg.net (I.M.); stefania.petrini@opbg.net (S.P.); eugenia.belcastro@unipi.it (E.B.)
  • Author Contributions: Conceptualization, F.C., S.S., C.B., D.V.D., D.R. and A.F.; methodology, G.P., F.C., S.P., I.M., S.S., C.B., F.F., E.B. and A.F.; investigation, G.P., F.C., I.M., S.S., C.B., F.F., C.M., A.C., D.R. and A.F.; data curation, F.C., S.P., S.S., C.B., C.M. and A.C.; writing—original draft preparation, F.C., S.S., C.B. and A.F.; writing—review and editing, A.F. and F.C.; supervision, A.F.; project administration, A.F.; funding acquisition, A.F. All authors have read and agreed to the published version of the manuscript.

Reference

  1. Sennato, S.; Paldino, G.; Bombelli, C.; Mezzani, I.; Petrini, S.; Belcastro, E.; Delfino, D.V.; Fiorentino, F.; Marianecci, C.; Ciogli, A.; et al. Optimization of Lipoplexes Functionalized with a Sialic Acid Mimetic (F9-PEG) to Target the C1858T PTPN22 Variant for Preclinical Assessment of a Novel Immunotherapy in Endocrine Autoimmunity. Pharmaceutics 2025, 17, 710. [Google Scholar] [CrossRef] [PubMed]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Sennato, S.; Paldino, G.; Bombelli, C.; Mezzani, I.; Petrini, S.; Belcastro, E.; Delfino, D.V.; Fiorentino, F.; Marianecci, C.; Ciogli, A.; et al. Correction: Sennato et al. Optimization of Lipoplexes Functionalized with a Sialic Acid Mimetic (F9-PEG) to Target the C1858T PTPN22 Variant for Preclinical Assessment of a Novel Immunotherapy in Endocrine Autoimmunity. Pharmaceutics 2025, 17, 710. Pharmaceutics 2025, 17, 1601. https://doi.org/10.3390/pharmaceutics17121601

AMA Style

Sennato S, Paldino G, Bombelli C, Mezzani I, Petrini S, Belcastro E, Delfino DV, Fiorentino F, Marianecci C, Ciogli A, et al. Correction: Sennato et al. Optimization of Lipoplexes Functionalized with a Sialic Acid Mimetic (F9-PEG) to Target the C1858T PTPN22 Variant for Preclinical Assessment of a Novel Immunotherapy in Endocrine Autoimmunity. Pharmaceutics 2025, 17, 710. Pharmaceutics. 2025; 17(12):1601. https://doi.org/10.3390/pharmaceutics17121601

Chicago/Turabian Style

Sennato, Simona, Giorgia Paldino, Cecilia Bombelli, Irene Mezzani, Stefania Petrini, Eugenia Belcastro, Domenico Vittorio Delfino, Francesco Fiorentino, Carlotta Marianecci, Alessia Ciogli, and et al. 2025. "Correction: Sennato et al. Optimization of Lipoplexes Functionalized with a Sialic Acid Mimetic (F9-PEG) to Target the C1858T PTPN22 Variant for Preclinical Assessment of a Novel Immunotherapy in Endocrine Autoimmunity. Pharmaceutics 2025, 17, 710" Pharmaceutics 17, no. 12: 1601. https://doi.org/10.3390/pharmaceutics17121601

APA Style

Sennato, S., Paldino, G., Bombelli, C., Mezzani, I., Petrini, S., Belcastro, E., Delfino, D. V., Fiorentino, F., Marianecci, C., Ciogli, A., Rotili, D., Ceccacci, F., & Fierabracci, A. (2025). Correction: Sennato et al. Optimization of Lipoplexes Functionalized with a Sialic Acid Mimetic (F9-PEG) to Target the C1858T PTPN22 Variant for Preclinical Assessment of a Novel Immunotherapy in Endocrine Autoimmunity. Pharmaceutics 2025, 17, 710. Pharmaceutics, 17(12), 1601. https://doi.org/10.3390/pharmaceutics17121601

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop